《大行报告》大摩下调中国平安(02318.HK)目标价至118元 评级「增持」
摩根士丹利发表报告表示,指计入中国平安(02318.HK)去年业绩表现,当中寿险新业务价值按年跌35%,并较预期低6%,决定下调廿对公司今年新业务价值预期7%至542亿元人民币,但仍相等於较去年增长9%。
该行指,下调对中国平安於2022年预期6%,但维持增长率在15%。
大摩表示,降中国平安今明两年经营溢利预期分别2%及5%,目标价降2%,由121元降至118元,此按综合方式作估值,反映股息预测下调因素,维持「增持」评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.